Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-24-097461
Filing Date
2024-11-13
Accepted
2024-11-13 16:05:50
Documents
69
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT ea0220325-10q_chinaphar.htm   iXBRL 10-Q 661551
2 CERTIFICATION ea022032501ex31-1_china.htm EX-31.1 10277
3 CERTIFICATION ea022032501ex31-2_china.htm EX-31.2 10355
4 CERTIFICATION ea022032501ex32-1_china.htm EX-32.1 5514
  Complete submission text file 0001213900-24-097461.txt   4521847

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE cphi-20240930.xsd EX-101.SCH 40744
6 XBRL CALCULATION FILE cphi-20240930_cal.xml EX-101.CAL 42347
7 XBRL DEFINITION FILE cphi-20240930_def.xml EX-101.DEF 227471
8 XBRL LABEL FILE cphi-20240930_lab.xml EX-101.LAB 410263
9 XBRL PRESENTATION FILE cphi-20240930_pre.xml EX-101.PRE 245224
72 EXTRACTED XBRL INSTANCE DOCUMENT ea0220325-10q_chinaphar_htm.xml XML 420225
Mailing Address 2ND FLOOR, NO. 17, JINPAN ROAD HAIKOU HAINAN PROVINCE F4 570216
Business Address 2ND FLOOR, NO. 17, JINPAN ROAD HAIKOU HAINAN PROVINCE F4 570216 8689866811730
CHINA PHARMA HOLDINGS, INC. (Filer) CIK: 0001106644 (see all company filings)

EIN.: 731564807 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34471 | Film No.: 241454083
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)